Polymers in Medicine

Polim. Med.
Scopus CiteScore: 3.5 (CiteScore Tracker 3.6)
Index Copernicus (ICV 2023) – 121.14
MEiN – 70
ISSN 0370-0747 (print)
ISSN 2451-2699 (online) 
Periodicity – biannual

Download PDF

Polymers in Medicine

2014, vol. 44, nr 4, October-December, p. 221–230

Publication type: original article

Language: English

In Situ Cross-Linked Matrix Tablets for Sustained Salbutamol Sulfate Release – Formulation Development by Statistical Optimization

Jadupati Malakar1,A,B,C,E,F, Krishnagopal Das1,B,C, Amit Kumar Nayak2,A,C,D,E

1 Department of Pharmaceutics, Bengal College of Pharmaceutical Sciences and Research, Durgapur, West Bengal, India

2 Department of Pharmaceutics, Seemanta Institute of Pharmaceutical Sciences, Odisha, India

Abstract

Background. The use of natural polymers in designing of matrix tablets for sustained-release drug delivery systems has received much attention.
Objectives. The study involves the development and optimization of in situ cross-linked matrix tablets for sustained salbutamol sulfate release.
Material and Methods. In situ cross-linked matrix tablets of salbutamol sulfate were prepared by direct compression and optimized by response surface methodology based on 32 factorial design. The influence on sodium alginate and a calcium salt (calcium carbonate) amounts in salbutamol sulfate matrix tablets on the properties like drug release and hardness of salbutamol sulfate sustained release matrix tablets were analyzed by response surface plots and corresponding contour plots. Drug contents, weight variations, hardness, and in vitro drug release with release kinetic analysis of these newly developed matrix tablets were also investigated.
Results. All these in situ cross-linked salbutamol sulfate matrix tablets showed satisfactory drug contents, weight variations, hardness and prolonged sustained release of salbutamol sulfate over 6 h.
Conclusion. The developed salbutamol sulfate matrix tablets might be beneficial over the conventional tablets to decrease the dosing frequency and enhanced patient compliance.

Key words

salbutamol sulfate, matrix tablets, sustained release, optimization, factorial design

References (42)

  1. Gohel M.C., Parikh R.K., Aghra P.Y., Nagori S.A., Delvadia R.R., Dabhi, R.R.: Application of simplex lattice design and desirability function for the formulation development of mouth dissolving film of salbutamol sulphate. Curr. Drug Deliv. 2009, 6, 486–494.
  2. Fattah E.A.E., Grant D.J.W., Gabr K.E., Meshali M.M.: Physical characteristics and release behaviour of salbutamol sulphate beads prepared with different ionic polysaccharides. Drug Dev. Ind. Pharm. 1998, 24, 541–547.
  3. Vasantha P.V., Puratchikody A., Mathew S.T., Balaraman A.K.: Development and characterization of Eudragit based mucoadhesive buccal patches of salbutamol sulphate. Saudi Pharm. J. 2011, 19, 207–214.
  4. Puratchikody A., Vasantha P.V., Mathew S.T., Balaraman A.K.: Development and characterization of mucoadhesive patches of salbutamol sulfate for unidirectional buccal drug delivery. Acta Pharm. 2011, 61, 157–170.
  5. Singh S., Soni R., Rawat M.K., Jain A., Deshpande S.B., Singh S.K., Muthu, M.S.: In vitro and in vivo evaluation of buccal bioadhesive films containing salbutamol sulphate. Chem. Pharm. Bull. 2010, 58, 307–311.
  6. Basak S.C., Kumar K.S., Ramalingam M.: Design and release characteristics of sustained release tablet containing metformin HCl. Brazilian J. Pharm. Sci. 2008, 44(3), 477–483.
  7. Malakar J.; Nayak A.K.: Theophylline release behavior for hard gelatin capsules containing various hydrophilic polymers. J. Pharm. Educ. Res. 2012, 3, 10–16.
  8. Malakar J.; Nayak A.K.; Goswami S.: Use of response surface methodology in the formulation and optimization of bisoprolol fumarate matrix tablets for sustained drug release. ISRN Pharmaceutics 2012: Article ID 730624.
  9. Üner M.; Celebi B.: Design of hydralazine hydrochloride matrix tablets based on various polymers and lipids. Indian J. Pharm. Educ. Res. 2012, 46, 75–87.
  10. Abdel-Rahman S.I., Mahrous G.M., El-Badry M.: Preparation and comparative evaluation of sustained release metoclopramide hydrochloride matrix tablets. Saudi Pharm. J. 2009, 17, 283–288.
  11. Gohel M.C., Parikh R.K., Nagori S.A., Jena D.G.: Fabrication of modified release tablet formulation of metoprolol succinate using hydroxypropyl methylcellulose and xanthan gum. AAPS Pharm. Sci. Tech. 2009, 10, 62–68.
  12. Joshi N.C., Ahamad Z., Mishra S.K., Sing R.: Formulation and evaluation of matrix tablet of tramadol hydrochloride. Indian J. Pharm. Educ. Res. 2011, 45, 360–363.
  13. Jian H., Zhu L., Zhang W., Sun D., Jiang J.: Galactomannan (from Gleditsia sinensis Lam.) and xanthan gum matrix tablets for controlled delivery of theophylline: In vitro drug release and swelling behaviour. Carbohydr. Polym. 2012, 87, 2176– 2182.
  14. Fan J., Wang K., Liu M., He Z.: In vitro evaluations of konjac glucomannan and xanthan gum mixture as the sustained release material of matrix tablet. Carbohydr. Polym. 2008, 73, 241–247.
  15. Pachuau L., Majumder B.: Albizia procera gum as an excipient for oral controlled release matrix tablet. Carbohydr. Polym. 2012, 90, 289–295.
  16. Ghosh S., Pal S.: Modified tamarind kernel polysaccharide: A novel matrix for control release aspirin. Int. J. Biol. Macromol. 2013, 58, 296–300.
  17. Sinha V.R., Al-Azaki A.A., Kumar R.V.: Novel Lenna woodier gum matrices for controlled release of drugs. Carbohydr. Polym. 2011, 83, 1492–1498.
  18. Singh K., Kumar A., Langyan N., Ahuja M.: Evaluation of Mimosa pudica seed mucilage as sustained-release excipient. AAPS Pharm. Sci. Tech. 2009, 10, 1121–1127.
  19. Chivate A.A., Poddar S.S., Abdul S., Savant G.: Evaluation of Sterculia foetida gum as controlled release excipient. AAPS Pharm. Sci. Tech. 2008, 9, 197–204.
  20. Varshosaz J., Tavakoli N., Kheirolahi F.: Use of hydrophilic natural gums in formulation of sustained-release matrix tablets of tramadol hydrochloride. AAPS Pharm. Sci. Tech. 2006, 17, E1–E7.
  21. Bamiro O.A., Odeku O.A., Sinha V.R., Kumar R.: Terminalia gum as a directly compressible excipient for controlled drug delivery. AAPS Pharm. Sci. Tech. 2012; 13, 16–23.
  22. Emeje M.O., Franklin-Ude P.I.F., Odoefule S.I.: Evaluation of the fluid uptake kinetics and drug release from gellan gum tablets containing metronidazole. Int. J. Biol. Macromol. 2010, 47, 158–163.
  23. Sriamornsak P., Sungthongjeen S.: Modification of theophylline release with alginate gel formed in hard capsules. AAPS Pharm. Sci. Tech. 2007, 8, Article 51.
  24. Goh C.H., Heng P.W.S., Chan L.W.: Alginates as a useful natural polymer for microencapsulation and therapeutic applications. Carbohydr. Polym. 2012, 88, 1–12.
  25. Banerjee S., Singh S., Bhattacharya S.S., Chattopadhyay P.: Trivalent ion cross-linked pH sensitive alginate-methyl cellulose blend hydrogel beads from aqueous template. Int. J. Biol. Macromol. 2013, 57, 297–307.
  26. Nayak A.K., Pal D., Pradhan J., Hasnain M.S.: Fenugreek seed mucilage-alginate mucoadhesive beads of metformin HCl: Design, optimization and evaluation. Int. J. Biol. Macromol. 2013, 54, 144–154.
  27. Nayak A.K., Pal D.: Formulation optimization and evaluation of jackfruit seed starch-alginate mucoadhesive beads of metformin HCl. Int. J. Biol. Macromol. 2013, 59, 264–272.
  28. Nayak A.K., Pal D., Santra K.: Plantago ovata F. mucilage-alginate mucoadhesive beads for controlled release of glibenclamide: Development, optimization and in vitro-in vivo evaluation. J. Pharmaceutics 2013; Article ID 151035.
  29. Nayak A.K., Das B., Maji R.: Calcium alginate/gum Arabic beads containing glibenclamide: Development and in vitro characterization. Int. J. Biol. Macromol. 2012, 51, 1070–1078
  30. Mandal S., Bau S.K., Sa B.: Sustained release of a water-soluble drug from alginate matrix tablets prepared by wet granulation method. AAPS Pharm. Sci. Tech. 2009, 10, 1348–1356.
  31. Mandal S., Bau S.K., Sa B.: Ca2+ ion cross-linked interpenetrating network matrix tablets of polyacrylamide-grafted-sodium alginate and sodium alginate for sustained release of diltiazem hydrochloride. Carbohydr. Polym. 2010, 82, 867–873.
  32. Giunchedi P., Gavini E., Moretti M.D., Pirisino G.: Evaluation of alginate compressed matrixes as prolonged drug delivery systems. AAPS Pharm. Sci. Tech. 2000, 1, 31–36.
  33. Nokhodchi A., Tailor A.: In situ cross-linking of sodium alginate with calcium and aluminum ions to sustained the release of theophylline from polymeric matrices. IL Farmaco 2004, 59, 999–1004.
  34. Saeedi M., Akbari J., Enayatifard R., Morteza-Semnani K., Tahernia M., Valizadeh H.: In situ cross-linking of polyanionic polymers to sustain the drug release from theophylline tablets. Iran. J. Pharm. Res. 2009, 8, 241–249.
  35. Malakar J., Nayak A.K., Pal D.: Development of cloxacillin loaded multiple-unit alginate-based floating system by emulsiongelation method. Int. J. Biol. Macromol. 2012, 50, 138–147.
  36. Malakar J., Nayak A.K., Jana P., Pal D.: Potato starch-blended alginate beads for prolonged release of tolbutamide: Development by statistical optimization and in vitro characterization. Asian J. Pharm. 2013, 7, 43–51.
  37. Nayak A.K., Das B., Maji R.: Gastroretentive hydrodynamically balanced systems of ofloxacin: In vitro evaluation. Saudi Pharm. J. 2013, 21, 113–117.
  38. Malakar J., Nayak A.K.: Formulation and statistical optimization of multiple-unit ibuprofen-loaded buoyant system using 23-factorial design. Chem. Eng. Res. Des. 2012, 9, 1834–1846.
  39. Guru P.R., Nayak A.K., Sahu R.K.: Oil-entrapped sterculia gum-alginate buoyant systems of aceclofenac: Development and in vitro evaluation. Colloids Surf. B: Biointerf. 2013, 104, 268–275.
  40. Nayak A.K., Laha B., Sen K.K.: Development of hydroxyapatite-ciprofloxacin bone-implants using »Quality by design«. Acta Pharm. 2011, 61, 25–36.
  41. US Pharmacopoeia National Formulary, USP 23/NF 18, United States Pharmacopoeia Convention Inc., Rockville, MD, 2000.
  42. Allen L.V., Popovich N.G., Ansel H.C.: Ansel’s pharmaceutical dosage forms and drug delivery systems, 8th edition, Lippincott Williams & Wilkins, Philadelphia 2004.